| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |